Your browser doesn't support javascript.
loading
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment.
Nolla, Kyle; Benjamin, David J; Cella, David.
Affiliation
  • Nolla K; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. kylenolla@northwestern.edu.
  • Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, CA, USA.
  • Cella D; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Nat Rev Urol ; 20(7): 420-433, 2023 07.
Article in En | MEDLINE | ID: mdl-36928615
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Guideline Language: En Journal: Nat Rev Urol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Guideline Language: En Journal: Nat Rev Urol Year: 2023 Type: Article Affiliation country: United States